Francis Arickx
AuthID: R-00H-AKJ
1
TÃTULO: Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation Full Text
AUTORES: Patricia Vella Bonanno; Michael Ermisch; Brian Godman; Antony P Martin; Jesper Van den Bergh; Liudmila Bezmelnitsyna; Anna Bucsics; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Irene Eriksson; Jurij Fuerst; Mohamed Gad; Ieva Greiciute Kuprijanov; Martin van der Graaff; Jolanta Gulbinovic; Jan Jones; Roberta Joppi; ...Mais
PUBLICAÇÃO: 2017, FONTE: FRONTIERS IN PHARMACOLOGY, VOLUME: 8, NÚMERO: AUG
AUTORES: Patricia Vella Bonanno; Michael Ermisch; Brian Godman; Antony P Martin; Jesper Van den Bergh; Liudmila Bezmelnitsyna; Anna Bucsics; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Irene Eriksson; Jurij Fuerst; Mohamed Gad; Ieva Greiciute Kuprijanov; Martin van der Graaff; Jolanta Gulbinovic; Jan Jones; Roberta Joppi; ...Mais
PUBLICAÇÃO: 2017, FONTE: FRONTIERS IN PHARMACOLOGY, VOLUME: 8, NÚMERO: AUG
INDEXADO EM: Scopus WOS
2
TÃTULO: Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways Full Text
AUTORES: Michael Ermisch; Anna Bucsics; Patricia Vella Bonanno; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Jurij Furst; Kristina Garuoliene; Martin van der Graaff; Jolanta Gulbinovic; Alan Haycox; Jan Jones; Roberta Joppi; Ott Laius; Irene Langner; Antony P Martin; Vanda Markovic Pekovic; Laura McCullagh; ...Mais
PUBLICAÇÃO: 2016, FONTE: FRONTIERS IN PHARMACOLOGY, VOLUME: 7
AUTORES: Michael Ermisch; Anna Bucsics; Patricia Vella Bonanno; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Jurij Furst; Kristina Garuoliene; Martin van der Graaff; Jolanta Gulbinovic; Alan Haycox; Jan Jones; Roberta Joppi; Ott Laius; Irene Langner; Antony P Martin; Vanda Markovic Pekovic; Laura McCullagh; ...Mais
PUBLICAÇÃO: 2016, FONTE: FRONTIERS IN PHARMACOLOGY, VOLUME: 7
INDEXADO EM: WOS